Unlike non-RA-related ILD, the development of RA-ILD involves factors closely related to RA itself, such as abnormal activity of PAD, which is strongly associated with the production of autoantibodies, including ACPA (153). Here, PRTN3 is linked to rheumatoid arthritis.